Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.29%5.24B | 1.38%4.88B | -13.77%1.25B | 4.72%1.3B | 1.25B | 1.09B | 0.58%4.82B | 1.45B | 1.24B | -28.92%4.79B |
| Cost of revenue | 3.14%3.44B | 4.03%3.34B | -16.70%874.57M | 14.35%908.7M | 828.69M | 724.19M | 5.42%3.21B | 1.05B | 794.66M | -9.68%3.04B |
| Gross profit | 16.22%1.8B | -3.89%1.55B | -6.15%378.1M | -12.50%388.94M | 417.46M | 364.3M | -7.83%1.61B | 402.86M | 444.5M | -48.15%1.75B |
| Operating expense | 2.39%1.35B | 8.00%1.31B | 3.15%346.95M | 8.71%329.36M | 318.94M | 319.42M | 7.10%1.22B | 336.37M | 302.96M | -9.94%1.14B |
| Operating profit | 93.86%453.88M | -40.61%234.13M | -53.15%31.16M | -57.90%59.59M | 98.52M | 44.88M | -35.57%394.26M | 66.5M | 141.54M | -71.00%611.93M |
| Net non-operating interest income (expenses) | -47.98%-9.29M | -11.39%-6.28M | 13.23%-1.5M | -0.20%-1.54M | -1.59M | -1.65M | 30.06%-5.64M | -1.73M | -1.54M | 22.33%-8.06M |
| Non-operating interest income | 460.00%140K | -98.62%25K | 750.00%17K | --0 | --7K | --1K | 7,454.17%1.81M | --2K | --0 | -59.32%24K |
| Non-operating interest expense | 49.61%9.43M | -15.38%6.3M | -12.35%1.52M | 0.20%1.54M | --1.6M | --1.65M | -7.83%7.45M | --1.73M | --1.54M | -22.54%8.08M |
| Net investment income | 308.67%9.37M | -234.50%-4.49M | -706.87%-795K | 161.80%474K | -543K | -3.63M | -46.19%-1.34M | 131K | -767K | -120.46%-918K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -3,271.31%-646.25M | -522.60%-19.17M | -969.13%-24.19M | 0 | 311.47%4.54M | 2.78M | 0 | -52.67%-2.15M | ||
| Less:Other special charges | 3,185.35%576.53M | -311.95%-18.69M | -391.09%-13.67M | --0 | ---- | ---- | -311.47%-4.54M | ---2.78M | --0 | 52.67%2.15M |
| Less:Write off | 84.17%69.72M | --37.86M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -74.59%3.87M | 192.26%15.22M | 292.95%12.65M | 101.00%214K | 545K | 1.81M | -318.10%-16.49M | 3.22M | -21.45M | -29.77%7.56M |
| Income before tax | -185.87%-188.42M | -41.54%219.41M | -75.57%17.32M | -50.14%58.73M | 101.95M | 41.41M | -38.31%375.32M | 70.9M | 117.78M | -71.22%608.37M |
| Income tax | -124.12%-24.63M | -22.93%102.12M | 22.59%33.37M | -51.17%19.88M | 35.05M | 13.82M | -38.05%132.51M | 27.22M | 40.72M | -69.87%213.89M |
| Net income | -239.65%-163.79M | -51.69%117.29M | -136.73%-16.04M | -49.59%38.85M | 66.9M | 27.58M | -38.45%242.81M | 43.68M | 77.07M | -71.90%394.48M |
| Net income continuous operations | -239.65%-163.79M | -51.69%117.29M | -136.73%-16.04M | -49.59%38.85M | --66.9M | --27.58M | -38.45%242.81M | --43.68M | --77.07M | -71.90%394.48M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -239.65%-163.79M | -51.69%117.29M | -136.73%-16.04M | -49.59%38.85M | 66.9M | 27.58M | -38.45%242.81M | 43.68M | 77.07M | -71.90%394.48M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -239.65%-163.79M | -51.69%117.29M | -136.73%-16.04M | -49.59%38.85M | 66.9M | 27.58M | -38.45%242.81M | 43.68M | 77.07M | -71.90%394.48M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -239.66%-60.5 | -51.71%43.32 | -136.74%-5.93 | -49.63%14.34 | 24.72 | 10.19 | -38.45%89.7 | 16.1411 | 28.4695 | -71.90%145.73 |
| Diluted earnings per share | -239.66%-60.5 | -51.71%43.32 | -136.75%-5.93 | -49.63%14.34 | 24.7152 | 10.19 | -38.45%89.7 | 16.1377 | 28.4695 | -71.90%145.73 |
| Dividend per share | 50.00%15 | 10 | 10 | |||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |